Pfenex applauds Reps. Susan Brooks and Anna Eshoo for their bipartisan leadership on strengthening our national biodefense programs through the introduction of H.R. 3299. The Strengthening Public Health Emergency Response Act of 2015 offers two key provisions that will play a major role in supporting the U.S.’ biodefense and biosecurity efforts, ultimately ensuring the safety of the American people.
Pfenex supports the Priority Review Voucher (PRV) provision in H.R. 3299, as we have long held that Congress should provide PRVs to encourage the development of medical countermeasures (MCMs) for the 13 deadly pathogens identified by the Department of Homeland Security as national security threats. We are also supportive of the bill’s provision to amend the Biomedical Advanced Research and Development Authority (BARDA) contracting process. This legislation would allow BARDA to manage its own MCM development and procurement contracts, as it has in the past, and ensure BARDA can successfully carry out its unique national security mission within the Department of Health and Human Services.
We look forward to the successful passage of H.R. 3299 through Congress as an important step to strengthening our biodefense programs, thereby supporting the safety of the American public.